Valneva SE (VALN) Depreciation & Amortization - Total (2022 - 2026)

Valneva SE (VALN) posted quarterly Depreciation & Amortization - Total of $4.8 million for Q1 2026, little changed year-on-year from $4.8 million in Q1 2025, and down 2.33% on a QoQ basis from $4.9 million in Q4 2025.

Valneva SE (VALN) Depreciation & Amortization - Total (2022 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Depreciation & Amortization - Total for 5 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Depreciation & Amortization - Total changed 0.0% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.2 million (up 9.74% YoY) and the FY2025 annual result came in at $19.2 million, up 14.97% from the prior year.
  • Depreciation & Amortization - Total fell to $4.8 million in Q1 2026 per VALN's latest filing, from $4.9 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization - Total for VALN reached as high as $12.0 billion in Q3 2022 and fell as low as -$12.0 billion in Q4 2022.
  • A 5-year average of $4.1 million and a median of $4.2 million in 2024 frame the typical range for Depreciation & Amortization - Total.
  • The largest YoY upside for Depreciation & Amortization - Total was 100.03% in 2023 against a maximum downside of 99.97% in 2023.
  • Year by year, Depreciation & Amortization - Total stood at -$12.0 billion in 2022, then soared by 100.03% to $3.9 million in 2023, then grew by 17.65% to $4.6 million in 2024, then climbed by 7.5% to $4.9 million in 2025, then dropped by 2.33% to $4.8 million in 2026.
  • According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $4.8 million, $4.9 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 4.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.78 Mn
Dec 31, 2025 4.89 Mn
Sep 30, 2025 4.78 Mn
Jun 30, 2025 4.78 Mn
Mar 31, 2025 4.78 Mn
Dec 31, 2024 4.55 Mn
Sep 30, 2024 4.21 Mn
Jun 30, 2024 3.98 Mn
Mar 31, 2024 3.98 Mn
Dec 31, 2023 3.87 Mn
Sep 30, 2023 3.41 Mn
Jun 30, 2023 3.19 Mn
Mar 31, 2023 2.96 Mn
Dec 31, 2022 -12.02 Bn
Sep 30, 2022 12.03 Bn